Cytosine arabinoside (Ara-C) has been the standard therapeutic agent for myelodysplastic syndromes (MDS) and adult acute myeloid leukemia (AML) patients for decades. Considerable progress has been made in development of new treatments for MDS/AML patients. but drug resistance remains a major clinical problem. Apoptotic bodies (ABs). https://thebrickes.shop/product-category/horseshoes/